Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center Memphis, TN, USA.
Front Immunol. 2013 Feb 20;4:38. doi: 10.3389/fimmu.2013.00038. eCollection 2013.
In response to inflammation, neutrophils deiminate histones and externalize chromatin. Neutrophil extracellular traps (NETs) are an innate immune defense mechanism, yet NETs also may aggravate chronic inflammatory and autoimmune disorders. Activation of peptidylarginine deiminase 4 (PAD4) is associated with NET release (NETosis) but the precise mechanisms of PAD4 regulation are unknown. We observed that, in human neutrophils, calcium ionophore induced histone deimination, whereas phorbol myristate acetate (PMA), an activator of protein kinase C (PKC), suppressed ionophore-induced deimination. Conversely, low doses of chelerythrine and sanguinarine, two inhibitors of PKC, reversed PMA inhibition and enhanced ionophore-stimulated deimination. In addition, a peptide inhibitor of PKCα superinduced ionophore activation of PAD4, thus identifying PKCα as the PMA-induced inhibitor of PAD4. At higher doses, chelerythrine, sanguinarine, and structurally unrelated PKC inhibitors blocked histone deimination, suggesting that a different PKC isoform activates histone deimination. We identify PKCζ as activator of PAD4 because a specific peptide inhibitor of this PKC isoform suppressed histone deimination. Confocal microscopy confirmed that, in the presence of PMA, NETosis proceeds without detectable histone deimination, and that ionophore cooperates with PMA to induce more extensive NET release. Broad inhibition of PKC by chelerythrine or specific inhibition of PKCζ suppressed NETosis. Our observations thus reveal an intricate antagonism between PKC isoforms in the regulation of histone deimination, identify a dominant role for PKCα in the repression of histone deimination, and assign essential functions to PKCζ in the activation of PAD4 and the execution of NETosis. The precise balance between opposing PKC isoforms in the regulation of NETosis affirms the idea that NET release underlies specific and vitally important evolutionary selection pressures.
针对炎症,中性粒细胞脱精氨酸并将染色质外化。中性粒细胞胞外诱捕网(NETs)是一种先天免疫防御机制,但 NETs 也可能加重慢性炎症和自身免疫性疾病。肽基精氨酸脱亚氨酶 4(PAD4)的激活与 NET 释放(NETosis)有关,但 PAD4 调节的确切机制尚不清楚。我们观察到,在人中性粒细胞中,钙离子载体诱导组蛋白脱精氨酸,而佛波醇肉豆蔻酸酯(PMA),一种蛋白激酶 C(PKC)的激活剂,抑制钙离子载体诱导的脱精氨酸。相反,低剂量的白屈菜红碱和血根碱,两种 PKC 的抑制剂,逆转了 PMA 的抑制作用,并增强了钙离子载体刺激的脱精氨酸。此外,一种 PKCα 的肽抑制剂超诱导钙离子载体激活 PAD4,从而确定 PKCα 是 PMA 诱导的 PAD4 抑制剂。在较高剂量下,白屈菜红碱、血根碱和结构上无关的 PKC 抑制剂阻断组蛋白脱精氨酸,表明不同的 PKC 同工型激活组蛋白脱精氨酸。我们将 PKCζ 鉴定为 PAD4 的激活剂,因为这种 PKC 同工型的特异性肽抑制剂抑制了组蛋白脱精氨酸。共聚焦显微镜证实,在 PMA 存在下,NETosis 进行而没有检测到明显的组蛋白脱精氨酸,并且钙离子载体与 PMA 合作诱导更广泛的 NET 释放。白屈菜红碱的广泛 PKC 抑制或 PKCζ 的特异性抑制抑制了 NETosis。我们的观察结果因此揭示了 PKC 同工型在调节组蛋白脱精氨酸中的复杂拮抗作用,确定了 PKCα 在抑制组蛋白脱精氨酸中的主导作用,并确定了 PKCζ 在激活 PAD4 和执行 NETosis 中的重要功能。在调节 NETosis 中相反的 PKC 同工型之间的精确平衡证实了 NET 释放是特定和至关重要的进化选择压力的观点。